Walleye Trading’s Revelation Biosciences Warrant REVBW Stock Holding History

Walleye Trading’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-93,435	Closed	-$654	–	4615
2024 Q4	$654	Sell	93,435 -11,555	-11%	-$135	﹤0.01%	4167
2024 Q3	$1.57K	Hold	104,990	–	–	﹤0.01%	3948
2024 Q2	$2.1K	Hold	104,990	–	–	﹤0.01%	4061
2024 Q1	$2.78K	Hold	104,990	–	–	﹤0.01%	4486
2023 Q4	$1.11K	Hold	104,990	–	–	﹤0.01%	4903
2023 Q3	$1.77K	Hold	104,990	–	–	﹤0.01%	4793
2023 Q2	$1.87K	Hold	104,990	–	–	﹤0.01%	4507
2023 Q1	$1.7K	Buy	+104,990	New	+$2.63K	﹤0.01%	4675
2022 Q3	–	Sell	-60,224	Closed	-$5K	–	5446
2022 Q2	$5K	Hold	60,224	–	–	﹤0.01%	4782
2022 Q1	$8K	Buy	+60,224	New	+$15.4K	﹤0.01%	5009
2021 Q4	–	Sell	-60,224	Closed	-$37K	–	5782
2021 Q3	$37K	Hold	60,224	–	–	﹤0.01%	4727
2021 Q2	$39K	Buy	60,224 +13,224	+28%	+$7.88K	﹤0.01%	4694
2021 Q1	$24K	Buy	+47,000	New	+$43.9K	﹤0.01%	4510

Other funds holding REVBW

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.18B AUM 26.57% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PIS

POM Investment Strategies Raleigh, North Carolina $80.5M AUM 16.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Walleye Trading's REVBW Position: Q1 2025 in Review

Walleye Trading sold out of Revelation Biosciences Warrant (REVBW) in Q1 2025, closing a stake of 93,435 shares — an estimated $654 sold.

Walleye Trading first reported a position in REVBW in Q1 2021 and held it in 13 quarters. The position peaked at $39K in Q2 2021. 9 funds tracked by Wall St. Rank hold REVBW as of Q1 2025.

Walleye Trading reported no remaining Revelation Biosciences Warrant position as of Q1 2025 after selling out during the quarter.
Walleye Trading sold 93,435 Revelation Biosciences Warrant shares in Q1 2025, an estimated $654.
Walleye Trading first reported a position in Revelation Biosciences Warrant in Q1 2021 and held it in 13 quarters.
Walleye Trading's Revelation Biosciences Warrant position peaked at $39K in Q2 2021.
9 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q1 2025.

Based on Walleye Trading's 13F filing for Q1 2025, filed 14 May 2025.